Plasmablastic Lymphoma: Clinical Trials

1 trial for Plasmablastic Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Plasmablastic Lymphoma: new trials by email Literature Review of Plasmablastic Lymphoma trials Research Report on Plasmablastic Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cytarabine - HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Phase 1 / Phase 2Active not recruitingAIDS Malignancy Consortium112016-06-232026-05-18

Narrower conditions

Burkitt Lymphoma (1)  ·  HIV Infections (1)  ·  Hodgkin Disease (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  DNA Virus Infections (1)  ·  Epstein-Barr Virus Infections (1)  ·  Genital Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)

Interventions

Carmustine (1)  ·  Cytarabine (1)  ·  Etoposide (1)  ·  Melphalan (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  carmustine, poliferprosan 20 drug combination (1)

Sponsors

AIDS Malignancy Consortium (1)

Countries

United States (1)

Top investigators

Mehrdad Abedi (1)

NIH funding

U01CA121947 (1)